RENB RENOVARO INC Dividend Policy Changes 8-K Filing 2024 - Financial Misstatement Enochian Biosciences Inc announced that its previous financial statements for the quarter ended March 31, 2024 contained a material misstatement regarding intangible assets, leading to an overstatement of assets and an understatement of losses, and plans to restate these financials. Additionally, the company has filed a lawsuit against Weird Science LLC and others for alleged fraudulent concealment related to a merger.Get access to all SEC 8-K filings of the RENOVARO INC